List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 5 studies with search of:   "Nifurtimox"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Conditions: Neuroblastoma;   Medulloblastoma
Interventions: Drug: Nifurtimox;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Zolendronic acid
2 Terminated Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis
Condition: Trypanosomiasis, African
Interventions: Drug: melarsoprol 1.8 mg/kg/d, 10d + nifurtimox 15/20 mg/kg/d, 10d;   Drug: melarsoprol 1.8 mg/kg/d, 10d + eflornithine 400 mg/kg/d, 7d;   Drug: nifurtimox 15/20 mg/kg/d 10d + eflornithine 400 mg/kg/d 7d
3 Terminated Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Condition: Trypanosomiasis, African
Intervention: Drug: Eflornithine plus Nifurtimox combination therapy
4 Recruiting Safety Study of Nifurtimox for Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Nifurtimox
5 Active, not recruiting Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis
Condition: Trypanosomiasis, African
Interventions: Drug: Eflornithine;   Drug: Nifurtimox

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services